Beijing
China
14
2025-03-20
The entities that hold a legal rights for patent applications filed by inventor Li Gong:
Gong Li from Beijing, CN has applied for patents for these inventions. The list has both pending applications and granted patents:
HETEROAROMATIC NITROGEN-OXIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
#2 | 2024-12-05P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
#3 | 2023-02-02RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF
#4 | 2022-12-08P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
#5 | 2022-03-03Double-stranded RNA molecule targeting CKIP-1 and use thereof
#6 | 2022-01-06RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
#7 | 2021-12-23Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof
#8 | 2021-06-17P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
#9 | 2020-07-23Double-stranded RNA molecule targeting CKIP-1 and use thereof
#10 | 2019-09-12Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
#11 | 2019-01-10Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
#12 | 2019-01-03Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
#13 | 2018-02-22Compound inhibiting activities of BTK and/or JAK3 kinases
#14 | 2016-08-11Compound inhibiting activities of BTK and/or JAK3 kinases
1617455 ⎘